Cubist to Present at December Investor Conference Oppenheimer Healthcare Conference 2012 Business Wire LEXINGTON, Mass. -- December 03, 2012 Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23^rd Annual Healthcare Conference in December 2012. Details are below. PRESENTER: Steve Gilman, EVP and Chief Scientific Officer EVENT: Oppenheimer 23^rd Annual Healthcare Conference DATE: Thursday, December 13, 2012 TIME: 10:35 a.m. Eastern Time LOCATION: The Waldorf Astoria, New York City WEBCAST: Live audio with slide webcast can be accessed here. About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website. Contact: Investors: Cubist Pharmaceuticals, Inc. Eileen C. McIntyre, 781-860-8533 Senior Director, Investor Relations email@example.com or Media: Cubist Pharmaceuticals, Inc. Julie DiCarlo, 781-860-8063 Senior Director, Corporate Communications firstname.lastname@example.org
Cubist to Present at December Investor Conference
Press spacebar to pause and continue. Press esc to stop.